CHICAGO, Aug. 14, 2024 /PRNewswire/ -- The global hematology analyzers and reagents market is expected to grow from USD 6.6 billion in 2024 to USD 8.8 billion by 2029, at a CAGR of 6.1%, driven by advancements in technology, an increase in blood disorder incidences, and the integration of flow cytometry with hematology analyzers. Key market drivers include rising technological innovations, such as new high-throughput platforms and fully automated systems by companies like HORIBA and Siemens Healthineers. However, growth is restrained by high costs and the slow adoption of advanced instruments in emerging economies, compounded by a shortage of skilled professionals. Opportunities for expansion exist in emerging markets with improving healthcare infrastructure and rising expenditures. North America leads the market due to high demand for blood components, while the Asia-Pacific region is anticipated to experience the most significant growth. Major players include Sysmex, Danaher, and Siemens Healthineers, with recent developments focusing on new product launches and partnerships.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146
Browse in-depth TOC on "Hematology Analyzers and Reagents Market"
282 - Tables
59 - Figures
308 - Pages
Market Competitiveness and Key Players
The hematology analyzers and reagents market is moderately competitive, with both established and emerging players vying for market share. Major companies in this sector as of 2023 include Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden Corporation (Japan), Siemens Healthineers (Germany), Abbott Laboratories (US), Boule Diagnostics AB (Sweden), Horiba, Ltd. (Japan), Bio-Rad Laboratories Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and F. Hoffmann-La Roche Ltd. (Switzerland). Key strategies employed by these companies include new product launches, partnerships, and expansions.
Sysmex Corporation (Japan)
Sysmex Corporation is a leading player in the hematology market, specializing in the development and manufacture of analyzers and reagents for hematology and hemostasis solutions. The company operates in over 40 countries and exports to more than 190 nations. Sysmex's strategy focuses on expanding its product portfolio through new product introductions and enhancements, alongside collaborations to boost R&D and raise global awareness of its offerings.
Danaher Corporation (US)
Danaher Corporation is a major stakeholder in the hematology analyzers and reagents market, known for its extensive range of blood analysis products. The company emphasizes acquisitions and partnerships to maintain its market position and foster future growth. Danaher's focus on R&D aims to deliver innovative solutions and strengthen its competitive edge.
Abbott Laboratories (US)
Abbott Laboratories is recognized for its innovative approach in the hematology field, concentrating on product launches within its Core Laboratory segment. The company's strategy centers around advancing its product offerings and maintaining its leadership through technological advancements. The US remains a critical revenue source, contributing approximately 39% of Abbott's total revenue in FY 2023.
Siemens Healthineers (Germany)
Siemens Healthineers is a significant market player known for integrating advanced technology, including artificial intelligence (AI), into its hematology analyzers. The company offers a comprehensive range of products designed to deliver accurate, reliable, and swift results, crucial for effective patient care. Siemens Healthineers benefits from a strong global presence and extensive distribution network.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
Mindray is a prominent competitor in the hematology analyzers and reagents market, recognized for its advanced automation and user-friendly interfaces. The company operates a robust distribution and service network, with subsidiaries in over 32 countries, supporting its global sales in 190 countries. Mindray also emphasizes strong customer support and training programs to ensure effective use of its products.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146
Product and Service Segmentation
The market for hematology analyzers and reagents is divided into hematology, hemostasis, and immunohematology products and services. Hematology products and services are expected to lead the market, driven by the increasing adoption of the "reagent rental" business model by providers. This trend is anticipated to support the segment's growth throughout the forecast period.
Price Range Analysis
Hematology analyzers and reagents are categorized into high-range, mid-range, and low-range price segments. Low-range analyzers are projected to dominate the market due to their cost-efficiency per sample test, which is expected to stimulate market expansion during the forecast period.
Application Segmentation
The market is also segmented by application into hemorrhagic conditions, immune system disorders, anemia, blood cancer, infectious diseases, and other categories. The hemorrhagic conditions segment is forecasted to lead the market, driven by the increased use of hematology analyzers to regularly monitor treatment effectiveness.
End-User Analysis
The hematology analyzers and reagents market includes hospital laboratories, commercial service providers, government reference laboratories, and research and academic institutes. Commercial service providers are anticipated to hold the largest market share due to the competitive advantages they offer compared to hospitals.
Geographical Insights
The market spans five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East. The Asia-Pacific region is expected to experience significant growth, driven by a large target patient population, increased incidence of thalassemia, and the growing geriatric population in several Asia-Pacific countries.
For more information, inquire now! Inquire Now
Related Reports:
Point of Care Diagnostics Market
Clinical Chemistry Analyzers Market
Life Science Instrumentation Market
In Vitro Diagnostics Market
Stoma Care Market
Get access to the latest updates on Hematology Analyzers and Reagents Companies and Hematology Analyzers and Reagents Market Size
About MarketsandMarkets:
MarketsandMarkets has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-hematology-analyzers-and-reagents-market-to-reach-usd-8-8-billion-by-2029--marketsandmarkets-302222072.html
